Novel soluble guanylate cyclase activators and their use

ll:\sxd\Interwovn\NRPortbl\DCC\SXD\15060390 _.docx-30/062017 CF3 1 N N \COOZ R3 R:] O-(CH2)n-R4 The invention relates to activators of soluble guanylate cyclase of formula (1) and their use 5 in pharmaceutical compositions, primarily topically administered ophthalmic compositions. The pharmaceutical...

Full description

Saved in:
Bibliographic Details
Main Authors Krauss, Achim Hans-Peter, Le Monnier De Gouville, Anne-Charlotte, Goodman, Krista B, Dodic, Nerina
Format Patent
LanguageEnglish
Published 20.07.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:ll:\sxd\Interwovn\NRPortbl\DCC\SXD\15060390 _.docx-30/062017 CF3 1 N N \COOZ R3 R:] O-(CH2)n-R4 The invention relates to activators of soluble guanylate cyclase of formula (1) and their use 5 in pharmaceutical compositions, primarily topically administered ophthalmic compositions. The pharmaceutical compositions are useful for reducing intraocular pressure in animals of the mammalian species.
Bibliography:Application Number: AU20170204542